Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2000
10/03/2000US6127522 CRFG-1a, a target and marker for chronic renal failure
10/03/2000US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments
10/03/2000US6127419 Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
10/03/2000US6127414 Antagonists of neuropeptide y and, in particular, in the treatment of cardiovascular diseases, e.g., vasoconstriction; hypotensive agents
10/03/2000US6127410 Compositions, apparatus and methods for facilitating surgical procedures
10/03/2000US6127403 An enzyme inhibitor for treating arteriosclerotic lesions of arteriosclerosis, hyperlipemia and diabetes, as well as ischemic diseases of brain, heart
10/03/2000US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease
10/03/2000US6127389 Benzimidazole derivatives as bradykinin agonists
10/03/2000US6127387 Use of CD4-binding small molecules to inhibit immune responses
10/03/2000US6127383 Treatment of arteriosclerosis
10/03/2000US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
10/03/2000US6127371 Endothelin receptor antagonists
10/03/2000US6127370 Method for treating alzheimer's disease
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000CA2274630C Preparation of ¬1s-¬1a,2b,3b,4a(s*)||-4-¬7-¬¬1-(3-chloro-2-thienyl) methyl|propyl|amino|-3h-imidazo¬4,5-b|pyridin-3-yl|-n-ethyl-2,3-dihydroxycyclopentanecarboxamide
09/2000
09/28/2000WO2000057186A1 Method for detecting predisposition to a venous thromboembolic disease
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056733A1 Triazolopyrimidinol compounds and salts thereof
09/28/2000WO2000056731A1 Novel method for producing doxazosin mesylate in a crystalline modification designated as form a
09/28/2000WO2000056730A1 PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
09/28/2000WO2000056719A1 FUSED PYRIDOPYRIDAZINE INHIBITORS OF cGMP PHOSPHODIESTERASE
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056711A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056709A1 Indolinone compounds as kinase inhibitors
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056685A1 Methods for the preparation of biphenyl isoxazole sulfonamides
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056357A2 Staphylococcus antigen and vaccine
09/28/2000WO2000056350A2 Methods of use of beta 1-integrin inhibitors
09/28/2000WO2000056349A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000WO2000056341A1 Chemical compounds and their uses
09/28/2000WO2000056331A1 Inhibitors of impdh enzyme
09/28/2000WO2000056330A1 Carnitine supplemented diet to prevent or alleviate ascites in broiler type poultry
09/28/2000WO2000056329A1 Preventives/remedies for arteriosclerosis
09/28/2000WO2000056328A1 Increasing cerebral bioavailability of drugs
09/28/2000WO2000056312A1 Treatment of pulmonary hypertension
09/28/2000WO2000056304A2 Anti-inflammatory uses of manzamines
09/28/2000WO2000056294A2 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry
09/28/2000WO2000056293A2 Medicaments containing doxazosin-mesylate of crystalline modification d
09/28/2000WO2000056289A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
09/28/2000WO2000056283A1 Inhibition of matrix metalloproteinases with polymers and pharmaceutical applications thereof
09/28/2000WO2000043392A3 Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000041481A3 Medicament forms having controlled release and containing active substances which easily dissolve in water
09/28/2000WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors
09/28/2000WO2000028332A9 Methods and compositions to lower plasma cholesterol levels
09/28/2000WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013712A3 Methods and compositions for the prevention or treatment of cancer
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000WO2000012118A9 Inhibiting cardiomyocyte death
09/28/2000WO2000003981A3 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
09/28/2000DE19912623A1 Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile A method for increasing the stability during storage and / or application of light-sensitive therapeutic systems or components thereof
09/28/2000CA2855415A1 Phenylalanine derivatives
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2377383A1 Apoptosis related genes
09/28/2000CA2368733A1 Phenylalanine derivatives
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2368041A1 Indolinone compounds as kinase inhibitors
09/28/2000CA2368024A1 Process for preparing [s-(r*,s*)]-.beta.-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives
09/28/2000CA2368023A1 Fused pyridopyridazine inhibitors of cgmp phosphodiesterase
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367916A1 Methods for the preparation of biphenyl isoxazole sulfonamides
09/28/2000CA2367903A1 Novel method for producing doxazosin mesylate in a crystalline modification designated as form a
09/28/2000CA2367899A1 Triazolopyrimidinol compounds and salts thereof
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367464A1 Materials and methods relating to modulation of p66 expression
09/28/2000CA2367048A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000CA2367002A1 Increasing cerebral bioavailability of drugs
09/28/2000CA2366877A1 Chemical compounds and their uses
09/28/2000CA2366859A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366652A1 Treatment of pulmonary hypertension
09/28/2000CA2366555A1 Method for detecting predisposition to a venous thromboembolic disease
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
1 ... 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 ... 1595